Document is current

Article History

Received: 7 March 2026

Accepted: 19 June 2026

First Online: 8 July 2026

Declarations

:

: Fernanda Hernández-González and Jacobo Sellares report honoraria for lectures, educational events, and support for attending meetings from Roche, Boehringer Ingelheim, AztraZeneca, Gebro, and GSK, outside the submitted work. Jacobo Sellares discloses consulting fees from Boehringer Ingelheim and Alofarma, and grants from Roche and Boehringer Ingelheim, all outside the submitted work. Jacobo Sellares is an Editorial Board member of Pulmonary Therapy . Jacobo Sellares was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Juan José Zapata-Huizi, Manuela Herrera-Tamayo, Josmar Jesvi Ríos-Poveda, and Eli Nancy Pérez-Rodas have nothing to disclose.

: This narrative review is based on previously published studies and does not include any new studies with human participants or animals performed by the authors. The studies and clinical trials cited herein have their own ethical review and approval procedures detailed in their respective protocols. In accordance with Hospital Clínic de Barcelona policies, this activity does not constitute human-subjects research, and institutional review board/ethics committee approval was not required.